CEFTAZIDIME SODIUM | PAI HOLDINGS PHARM | ||
EQ 10MG BASE/ML,EQ 20MG BASE/ML,EQ 40MG BASE/ML | |||
No | No | ||
Expired | Expired | ||
None | None | ||
None | No | ||
FORTAZ is indicated for the treatment of patients with infections: 1. Lower Respiratory Tract Infections 2. Skin and Skin-Structure Infections 3. Urinary Tract Infections 4. Bacterial Septicemia 5. Bone and Joint Infections 6. Gynecologic Infections 7. Intra-abdominal Infections 8. Central Nervous System Infections. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
EQ 10MG BASE/ML | ** | ** | - | - | - |
EQ 20MG BASE/ML | ** | ** | - | - | - |
EQ 40MG BASE/ML | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com